Scilex Holding Company, a Sorrento Company, Announces Pre-Emptive Pay Off of Remaining Balance of its Senior Secured Notes
Pre-emptive pay off of the Senior Secured Notes (the “Notes”) eliminated the prior $28.0 million…
Year: 2022
Aleafia Health Announces Results of Annual General Meeting
TORONTO, Sept. 29, 2022 (GLOBE NEWSWIRE) — Aleafia Health Inc. (TSX: AH, OTCQX: ALEAF) (“Aleafia…
Palisade Bio Announces Oral Presentation of Phase 2 Data at the American College of Surgeons (ACS) Clinical Congress 2022
Carlsbad, CA, Sept. 29, 2022 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI), a clinical stage biopharmaceutical…
Tarsus Launches “Look at the Lids” Campaign to Encourage Eye Care Professionals to Identify and Diagnose Demodex Blepharitis
Look at the Lids Website LookattheLids.com Demodex blepharitis is a highly prevalent, yet often missed…
T2 Biosystems Announces BARDA Exercise of Contract Option 3 Valued at $3.7 Million
Advances U.S. Clinical Trials and FDA Submission for T2Resistance and T2Biothreat Panels LEXINGTON, Mass., Sept….
Biomerica’s Aware® Breast Self Exam and EZ Detect™ Colon Disease Test Now Available on Amazon and Fulfilled by Amazon
Aware®is a simple at-home device to increase sensitivity in breast self-exams. About 80% of breast…
SELLAS Life Sciences Presents Poster at 2022 SOHO Meeting Highlighting Bioequivalence Data for GFH009 Formulations
GFH009 Formulation is Near Physiological pH, While Still Achieving Desired Effect – GFH009 at pH…
Ocuphire Expands Medical Advisory Board with Seven New KOLs and Strengthens Leadership Team
FARMINGTON HILLS, Mich., Sept. 29, 2022 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a…
Journal of Precision Medicine publication confirms GeneType Risk Test outperforms traditional risk assessments for breast cancer
MELBOURNE, Australia, Sept. 29, 2022 (GLOBE NEWSWIRE) — Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE,…
AXIM® Biotechnologies Point-of-Care Diagnostic Test Platform Sales Commence With Verséa Ophthalmics’ Commercial Launch at AAO 2022
Sales of Point-of-Care Diagnostic Tests for Ocular Surface Disease Commence at the American Academy of…
Recludix Pharma Announces the Appointment of Senior Executive Matthew S. Caldemeyer as Chief Business Officer
SAN DIEGO, Sept. 29, 2022 (GLOBE NEWSWIRE) — Recludix Pharma, a leader in platform approaches…
Ayala Pharmaceuticals to Host Key Opinion Leader Webinar on Desmoid Tumors
Event will feature a review of data from part A of the Phase 2/3 RINGSIDE…
BioVie to Participate in Cantor Fitzgerald’s Neurology & Psychiatry Conference
RENO, Nev., Sept. 29, 2022 (GLOBE NEWSWIRE) — BioVie Inc., (NASDAQ: BIVI) (“BioVie” or the…
aTyr Pharma Announces Notice of Allowance for U.S. Patent for Anti-Neuropilin-2 (NRP2) Monoclonal Antibodies
Compositions and methods patent covers antibodies targeting NRP2 which may have therapeutic applications in the…
Tenaya Therapeutics to Participate in Inaugural Hypertrophic Cardiomyopathy Medical Society’s 2022 Scientific Sessions
Encore Presentation of Lead Gene Therapy TN-201 Preclinical Data to be Featured in Late-Breaking Trials…
Selecta Biosciences Board Member, Timothy Springer, Ph.D., Wins Lasker Award for Seminal Discovery of Key Adhesion Molecules that Mediate Immune Cell Interactions
WATERTOWN, Mass., Sept. 29, 2022 (GLOBE NEWSWIRE) — Selecta Biosciences, Inc. (NASDAQ: SELB), a biotechnology…
CRISPR Therapeutics to Present at the BMO Biopharma Spotlight Series: Gene Editing and Therapy
ZUG, Switzerland and BOSTON, Sept. 29, 2022 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a…
Lisata Therapeutics’ Director and Scientific Founder of the CendR Platform™ Technology, Erkki Ruoslahti, M.D., Ph.D., Receives 2022 Albert Lasker Basic Medical Research Award
BASKING RIDGE, N.J., Sept. 29, 2022 (GLOBE NEWSWIRE) — Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata”…
Tenaya Therapeutics to Participate in Upcoming October Investor and Industry Conferences
SOUTH SAN FRANCISCO, Calif., Sept. 29, 2022 (GLOBE NEWSWIRE) — Tenaya Therapeutics, Inc. (NASDAQ: TNYA),…
Ocugen, Inc. to Present at Chardan’s 6th Annual Genetic Medicines Conference
MALVERN, Pa., Sept. 29, 2022 (GLOBE NEWSWIRE) — Ocugen, Inc. (“Ocugen” or the “Company”) (NASDAQ:…